# Effect of Intranasal Insulin on LH Concentrations in Man

> **NCT02154477** · PHASE1,PHASE2 · COMPLETED · sponsor: **Texas Tech University Health Sciences Center** · enrollment: 14 (actual)

## Conditions studied

- Hypogonadotropic Hypogonadism

## Interventions

- **DRUG:** intranasal insulin
- **DRUG:** placebo (intranasal saline)

## Key facts

- **NCT ID:** NCT02154477
- **Lead sponsor:** Texas Tech University Health Sciences Center
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-12
- **Primary completion:** 2017-12
- **Final completion:** 2017-12
- **Target enrollment:** 14 (ACTUAL)
- **Last updated:** 2019-08-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02154477

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02154477, "Effect of Intranasal Insulin on LH Concentrations in Man". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT02154477. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*